Information  X 
Enter a valid email address

Seed Innovations Ltd (SEED)

  Print   

Monday 17 January, 2022

Seed Innovations Ltd

Investee Company Update: Yooma Wellness Inc.

RNS Number : 7090Y
Seed Innovations Limited
17 January 2022
 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

17 January 2022

SEED Innovations Limited ("SEED" or the "Company")

Investee Company Update: Yooma Wellness Inc.

SEED Innovations Ltd, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space, is pleased to note an update by its portfolio company, Yooma Wellness Inc. ('Yooma'), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands.

Yooma has announced that Boots, Britain 's leading health and beauty retailer, will be stocking MYO Plant Nutrition brand ('MYO') in over 800 stores. The UK-based, 100%-plant built, nutrition business was acquired by Yooma in March 2021 and currently has its products available in  Holland & Barrett, Selfridges, Lloyds Pharmacy and Amazon. Boots will be stocking MYO's branched-chain amino acids, essential amino acids and functional spray products in stores.

SEED has a holding of 4,427,609 ordinary shares in Yooma representing approximately 4.4% of Yooma's issued share capital.

 

Ed McDermott, CEO of SEED, commented :   " We are pleased with the progress Yooma is making in the wellness and CBD sectors through its buy-and-build strategy. Boots is a major market leader in the UK health and beauty industry and we hope that this new relationship will create further shareholder value through this wide exposure and distribution of MYO."

 

The announcement by Yooma Wellness Inc is set out below without material changes or adjustments:

 

 

 

 17 January 2022

 

 

MYO Plant Nutrition  launches in Boots  across the UK

Products available in up to 838 stores across the UK

 

 

 

Yooma Wellness Inc. (CSE:YOOMAQSE:YOOM), a global vertically integrated wellness platform that develops and markets a portfolio of CBD and wellness brands,  is pleased to announce that Boots, the UK's leading health and beauty retailer, will stock MYO Plant Nutrition ('MYO') products.

 

The listing includes MYO's Plant Proteins in 838 stores, branched-chain amino acids (BCAA) and essential amino acids (EAA) in up to 574 stores, and functional sprays in 522 stores.

 

Launching  with Boots accelerates the momentum MYO has already seen in 2021, with products now available in  Holland & Barrett, Selfridges, Lloyds Pharmacy and Amazon, amongst others.

 

MYO products are 100 %-plant-based, use clean and innovative ingredients, and focus on the growing area of full-body plant-based wellness, which includes nutrition, the gut, brain, immunity and other key elements of wellness.  Furthermore, MYO holds a leading position with regards to sustainability by using recycled and recyclable outer packaging as well as biodegradable scoops and pouches.

 

James Lawson Baker, Founder of MYO Plant Nutrition, commented:   "This is a major milestone for MYO and we are absolutely delighted to be partnering with Boots, the leading health and beauty retailer in the UK.  A listing of this size gives the brand enormous national exposure and deepens our footprint within mainstream UK retail.  The listing will support MYO in  making plant-based active nutrition and wellness products mainstream and accessible.  The partnership is a testament to the high-quality product and brand offering that we have built over the past year.  We look forward to building our credibility amongst Boots' customers going forward."

 

Jordan Greenberg, CEO of Yooma , said:  "MYO Plant Nutrition is an exceptional example of how Yooma's buy-and-build strategy creates shareholder value.  MYO continues to surpass expectations with its increased availability in UK's most reputable retailers and it has the honour of being known as one of the few brands to have passed the FSA's validation assessment."

 

Yooma acquired MYO in March 2021, due to the growing market demand for p lant-based protein supplements, with a global market size estimated at US$4.3 billion in 2020, projected to grow at a CAGR of 7.2% during a forecast period 2021-2026.

 

About MYO Plant Nutrition

MYO Plant Nutrition is a UK-based plant nutrition business with a mission to help people improve their full-body wellness. With a comprehensive product portfolio, MYO helps address the key areas of wellness including nutrition, performance, immunity, cognitive health and gut health.  MYO is one of the few brands whose CBD products have passed the UK Food Standard Agency's ("FSA") rigorous validation assessment and a number of products are included on the FSA's public list.  The brand is stocked in Boots, Holland & Barrett and Lloyds Pharmacy amongst others.  For further information visit  www.myoplantnutrition.com .

 

About Yooma Wellness Inc.

Yooma's mission is to build a vertically-integrated global leader in the manufacturing, marketing, distribution, and sale of wellness products including hemp seed oil and hemp-derived and cannabinoid (CBD) ingredients.  The Company leverages strategically curated sales channels and ecommerce networks to deliver a diverse mix of wellness products through operating subsidiaries in the United States, United Kingdom, France and Japan.  Learn more at  www.yooma.ca .

 

***ENDS***

For further information on the Company please visit www.seedinnovations.co or contact:

 

 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: [email protected] 

 

James Biddle

Roland Cornish

Beaumont   Cornish   Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Catherine Leftley

Isabelle Morris

St Brides Partners Ltd,

Financial PR

E: [email protected]

 

 

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFLSLSIDLIF

a d v e r t i s e m e n t